Our top pick for
Itamar Medical Ltd is a medical devices business based in the US. Itamar Medical shares (ITMR) are listed on the NASDAQ and all prices are listed in US Dollars. Itamar Medical employs 257 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$16.36 - $30.91|
|50-day moving average||$30.57|
|200-day moving average||$24.64|
|Wall St. target price||$30.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.47|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2022-01-15)||N/A|
|1 month (2021-12-22)||N/A|
|3 months (2021-10-26)||-100.00%|
|6 months (2021-07-26)||-100.00%|
|1 year (2021-01-26)||-100.00%|
|2 years (2020-01-24)||-100.00%|
|3 years (2019-01-22)||N/A|
|5 years (2017-01-22)||N/A|
|Revenue TTM||$50.9 million|
|Gross profit TTM||$28.7 million|
|Return on assets TTM||-13.14%|
|Return on equity TTM||-35.33%|
|Market capitalisation||$506.9 million|
TTM: trailing 12 months
We're not expecting Itamar Medical to pay a dividend over the next 12 months.
Over the last 12 months, Itamar Medical's shares have ranged in value from as little as $16.36 up to $30.91. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Itamar Medical's is 0.5389. This would suggest that Itamar Medical's shares are less volatile than average (for this exchange).
Itamar Medical Ltd. , a medical technology company, develops and commercializes non-invasive medical devices and solutions for the treatment of respiratory sleep disorders. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enable to conduct home sleep apnea tests for the treatment of sleep apnea, such as obstructive sleep apnea; EndoPAT device that diagnoses endothelial dysfunction; and Loop device, a wrist device for measuring and recording physiological parameters, such as SpO2, respiration rate, and heart rate. The company operates in the United States, Canada, Europe, Israel, Japan, rest of the Asia Pacific, and internationally. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Everything we know about the Austin Gold IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.